Ganirelix Acetate 65219-0028-05
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 24, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA215658
Need to source Ganirelix Acetate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ganirelix Acetate | 250 ug/.5mL |
Drug Class
Decreased GnRH Secretion [PE]Gonadotropin Releasing Hormone Receptor Antagonist [EPC]Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
Selected Package
65219-0028-05Selected1 SYRINGE, GLASS in 1 CARTON (65219-028-05) / 1 mL in 1 SYRINGE, GLASS